ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.

ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device “ArcScan Insight® 100, ” headquartered in Golden, Colorado, announces the execution of a Stock Purchase Agreement …
( read original story …)

---